Search

Search Constraints

You searched for: Author/Creator Avezum, Alvaro

Search Results

31. Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis. Issue 6 (26th March 2020)

32. Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial. Issue 12 (December 2022)

33. Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial. Issue 12 (December 2022)

34. Depressive Symptoms and Risk of Acute Stroke: INTERSTROKE Case-Control Study. (25th April 2023)

35. Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide. Issue 1 (14th July 2017)

36. Does greater individual social capital improve the management of hypertension? Cross-national analysis of 61 229 individuals in 21 countries. Issue 4 (17th December 2017)

37. Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial. (20th September 2022)

38. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Issue 10193 (13th July 2019)

39. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Issue 10193 (13th July 2019)

40. Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial. Issue 4 (24th January 2022)